US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector
Condition: Multiple Sclerosis Intervention: Drug: Interferon-beta-1b (BETASERON, BAY 86-5046) Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Betaseron | Learning | Multiple Sclerosis | Research | Study | Universities & Medical Training